AUG 11, 2021 11:59 AM PDT

Mental Health-Where is COVID-19 Leading Us?

It has been established that there is no single cause of psychiatric illness. As with many other diseases, psychiatric illness is generally the result of a complex interplay between an individual’s genes and environment. Psychiatric illness is common in patients with COVID-19. However, until recently, available data on the subject has been limited to low levels of evidence. Last year, Labroots reported on the potential neuropsychiatric impacts of the COVID-19 pandemic, now studies are beginning to report on this phenomenon. 

In May 2021, a paper was published in Translational Psychiatry, documenting the results of a meta-analysis of psychiatric symptoms in individuals with, and survivors of, COVID-19. This high level of evidence revealed that multiple psychiatric symptoms can occur during the acute stage of COVID-19 infection and are primarily severe. While the severity declines over time during recovery, specific symptoms such as anxiety may remain even during the late recovery phase.

Multiple factors are thought to explain these symptoms, including the direct impact that the virus has on the central nervous system, triggers due to stressful events, and even some of the medications used to treat the disease. A combination of these, and potentially additional, factors are likely to blame. A study from Autumn 2020 reviewed the impact of COVID-19 on the mental health of a sample of Australian adults. Interestingly enough, the study suggested that social factors such as disruptions in employment were more highly related to psychiatric sequelae than exposure to COVID-19 itself. Indeed, loneliness is thought to play a substantial role. Effective treatment of psychiatric illness requires early intervention and access to care, both of which have been impeded due to lockdown procedures and other factors amid COVID-19.

Although sobering, these results have led to a renewed demand for psychiatric services and a call to institute measures to increase long overdue capacity and funding. In addition, we now have a high level of evidence to suggest the significance of early intervention and support for those experiencing psychiatric symptoms in the early stages of COVID-19 infection. These challenges highlight the importance of collaboration between mental health services and primary care providers. As systems evolve and become stronger under pressures that have been globally imposed upon them by this pandemic, it is essential to remain vigilant as new evidence continues to emerge. Continued professional inquiry will likely lead to novel innovations that contribute positively to ongoing healthcare transformation both domestically and abroad.

 

Sources: Translational Psychiatry, frontiers in Psychiatry, JAMA.


 
About the Author
  • Dr. Christopher DiMaio is a Science Writer at Labroots. He received his MD from Penn State College of Medicine in 2014. His academic and professional interests include Neuroscience, Behavioral health, Immunology, and Healthcare improvement, among others. He is an active part of his community.
You May Also Like
AUG 26, 2021
Microbiology
Some Herbal Medicines May Help Treat Tick-Borne Diseases
AUG 26, 2021
Some Herbal Medicines May Help Treat Tick-Borne Diseases
Ticks are vectors for disease; they can transmit pathogenic bacteria to animals and humans through their bites. Diseases ...
SEP 01, 2021
Genetics & Genomics
Do Some Friendships Have a Genetic Basis?
SEP 01, 2021
Do Some Friendships Have a Genetic Basis?
Have you ever felt an instantaneous connection with someone you just met? New research has suggested that there may be a ...
SEP 06, 2021
Drug Discovery & Development
Antibiotics Increase Colon Cancer Risk by 17%
SEP 06, 2021
Antibiotics Increase Colon Cancer Risk by 17%
People who take antibiotics are at an increased risk of developing colon cancer within five to ten years. The research w ...
SEP 07, 2021
Immunology
Designer Cells for Treating Arthritis Are Activated by Inflammation
SEP 07, 2021
Designer Cells for Treating Arthritis Are Activated by Inflammation
Scientists have developed a new cell therapy for arthritis that becomes activated in the presence of inflammation. When ...
SEP 07, 2021
Drug Discovery & Development
A giant step in treating growth disorders in children.
SEP 07, 2021
A giant step in treating growth disorders in children.
Hormone production and release is important in individuals of all ages but is especially important for children as hormo ...
SEP 12, 2021
Coronavirus
Real-World, Post-Delta COVID-19 Vaccine Data & Potential Treatment
SEP 12, 2021
Real-World, Post-Delta COVID-19 Vaccine Data & Potential Treatment
New research may have identified a potential treatment or preventive medication for SARS-CoV-2 and other viral infection ...
Loading Comments...